measurements of total drug plasma concentration.

[1]  D. Greenblatt,et al.  Diazepam kinetics in patients with renal insufficiency or hyperthyroidism. , 1981, British journal of clinical pharmacology.

[2]  F. Andreasen,et al.  The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis. , 2009, Acta pharmacologica et toxicologica.

[3]  W. Bennett,et al.  Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics. , 1980, Annals of internal medicine.

[4]  D. Drayer,et al.  Drug therapy in renal failure. , 1980, Annual review of pharmacology and toxicology.

[5]  T. Ludden,et al.  Excretion pathways of amphotericin B. , 1979, The Journal of infectious diseases.

[6]  R. Burney,et al.  Effects of pH on Protein Binding of Lidocaine , 1978, Anesthesia and analgesia.

[7]  P. Leren,et al.  Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. , 1978, Biochemical pharmacology.

[8]  J. Maddocks,et al.  The plasma half-life of antipyrine in chromic uraemic and normal subjects. , 1975, British journal of clinical pharmacology.

[9]  R. Gugler,et al.  Pharmacokinetics of drugs in patients with the nephrotic syndrome. , 1975, The Journal of clinical investigation.

[10]  E. Block,et al.  Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. , 1974, Annals of internal medicine.

[11]  J. Bennett,et al.  A pharmacologic guide to the clinical use of amphotericin B. , 1969, The Journal of infectious diseases.

[12]  J. Richardson,et al.  Therapy with amphotericin B of Candida septicemia in the presence of acute renal failure. , 1968, Investigative urology.